Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-part Study Top Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera

NCT01901432 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT01901432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01901432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-part Study Top Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera
Lead sponsor
Italfarmaco
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2013
Completion date
September 25, 2017
Enrollment
48 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera